- Mercia Technologies has provided an update on recent commercial progress across its life sciences and biosciences portfolio.

Mercia said it has a current portfolio of five "emerging stars" within the portfolio, which represent about 20% of the group's direct investment portfolio by value.

"Several of these companies are receiving high levels of commercial interest from strategic partners within their target sectors, and two of the portfolio are expected to be profitable during the current financial year," the company said.

At 9:54am: [LON:MERC] Mercia Technologies Plc share price was +0.25p at 34.25p

Story provided by